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A cDNA corresponding to the membrane receptor for 
growth hormone (GH) was amplified by polymerase chain 
reaction (peR) directly from human skin. The cDNA was 
cloned and found to have complete sequence homology to 
the extracellular domain of human liver GH receptor (GH-
R) . Northern analysis, using the cloned GH-R as probe, re-
vealed relatively higher levels of GH-R transcripts in cul-
tured human dermal fibroblasts compared to cultured 
keratinocytes or keratome biopsies. Semi-quantitative peR 
analysis indicated that the level of GH-R mRNA in cultured 
l11elanocytes was similar to that in fibroblasts. The receptor 
protein encoded by GH-R mRNA in fibroblasts was shown 
by affinity cross-linking to have an apparent Me of 115-
120 kDa, similar to that of 3T3-F442A fibroblasts used as a 
control. mRNA transcripts for the major mediator of GH 
actions, insulin-like growth factor 1 (IGF-l), were detected 
by peR in fibroblasts, melanocytes, and keratome biopsies, 
but not in keratinocytes. In contrast, IGF-l receptor mRNA 
were abundant in cultured keratinocytes and skin biopsies, as 
determined by Northern analysis. IGF-l but not GH (5-
50 ng/ml) promoted clonal proliferation of cultured kerati-
nocytes. In contrast, GH (10 ng/ml) after 5 d markedly in-
creased fibroblast cell numbers (70%, p < 0.009) over 0.2% 
serum control. These data indicate that human skin cells 
possess the molecular elements necessary to respond to GH 
and raise the possibility that GH may influence skin growth 
in vivo.] Invest Dermatol99:343-349, 1992 
---------------------------------------------------------------------------------------------------------
Growth hormone (GH) actions on linear bone growth and body metabolism have been studied for decades [1]. As proposed by the "somatomedin hypothesis." [2], many GH-mediated effects are exerted systeml-. . cally via stimulation of hepatic synthesis of insulin-
like growth factor 1 (IGF-l) [3 ,4]. Additional evidence for associa-
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tion between pituitary GH and hepatic production of IGF-1 has 
been obtained by cloning of GH receptor (GH-R) from liver of 
rabbit [5], human [5], rat [6], and mouse [7] . GH administered to 
older men with low plasma levels of IGF-l has been reported to 
cause increased skin thickness [8] . In addition, there are generalized 
effects of excess GH production in acromegaly on epidermal struc-
ture and function such as skin tags, coarsening of facial features, and 
acanthosis nigricans [9,10] . These effects are believed to be the 
result of indirect actions of circulating GH, presumably via in-
creased levels of liver-derived IGF-1 [1,4,10]. 
It is now evident that GH can act not only via systemic IGF-1 
synthesized and secreted by the liver but also directly via GH-R 
expressed on many target tissues [11] . GH-R transcripts have re-
cently been demonstrated in cultured cells in vitro [12,13], and in a 
number of rat tissues in vivo [6], but not in human skin. Positive 
immunoreactivity for GH-R and GH binding proteins (GHBP) was 
recently localized to basal and spinous keratinocytes, dermal fibro-
blasts, and hair matrix cells of the dermal papillae in human skin 
[14] . However, because the antibody used did not distinguish be-
tween the membrane-anchored GH-R and circulating GHBP [14], 
immunoreactivity alone does not provide direct evidence for ex-
pression of membrane-bound GH-R in skin. 
In this work, we have cloned a eDNA for the extracellular do-
main of GH-R directly from human skin and examined GH-R gene 
and protein expression in cultured human skin cells. In addition, we 
have confirmed and extended previous reports by directly demon-
strating IGF-1 and IGF-1 receptor (IGF-IR) mRNA expression in 
human keratinocytes, fibroblasts, and melanocytes. 
Our findings indicate that fibroblasts and melanocytes, but not 
keratinocytes, are the major sources of GH-R mRNA transcripts in 
human skin. Fibroblasts and melanocytes, but not keratinocytes, 
also express IGF-l mRNA. Because in vitro IGF-1 stimulates kera-
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tinocyte growth via their IGF-l receptors, these results suggest a 
role for IGF-l in keratinocyte growth regulation, and identify der-
mal fibroblasts and melanocytes as potential extrahepatic sources of 
GH-induced IGF-l synthesis in human skin. 
MATERIALS AND METHODS 
Skin Biopsies Keratome biopsies were procured from the but-
tocks of normal healthy volunteers, after obtaining written in-
formed consent, using 1 % lidocaine anesthetic as previously de-
scribed [15). Protocols for human subjects were approved by the 
University of Michigan Institutional Review Board. For RNA stud-
ies, biopsies were immediately frozen in liquid nitrogen and stored 
at -70 °C until use (see below). Biopsies used for initiation of pri-
mary cell cultures were incubated with trypsin-EDT A to achieve a 
single cell suspension [15). 
Fibroblast Cultures and Growth Assays Papillary dermal fi-
broblast (FB) cultures were initiated from keratome biopsies and 
propagated for up to 10 passages. Celles were seeded at 1 - 2 X 104 
cells/cmz in Dulbecco's modified Eagle's medium media (DMEM) 
supplemented with 10% fetal calf serum (FCS, GIBCO), re-fed 
every 48 h, and passaged once they had reached 6-8 X 104 cells/ 
cmz. For cell-proliferation experiments, FB growing in DMEM 
plus 10% FCS were harvested and 5 X 103 cells were seeded in 1 ml 
of DMEM plus 0.2% FCS in 35-mm dishes and allowed to attach 
and grow for 48 h. At this time the medium was replaced and cells 
were treated in DMEM plus 0.2% FCS to which had been added 
protein carrier-free pituitary GH (CALBIOCHEM, San Diego, 
CA) at indicated concentrations. FB were allowed to grow for 
3 or 5 d at which time they were trypsinized and counted in a 
hemocytometer. 
Keratinocyte Cultures and Growth Assays Primary cultures 
of human KC were derived from keratome biopsies and subcultured 
in MCDB 153 medium modified for high-density growth [16) 
supplemented with 0.15-mM Ca++, hydrocortisone (HC, 0.5/1g/ 
ml), bovine pituitary extract (BPE, 0.4%), insulin from bovine pan-
creas (5 /1g/ml), and epidermal growth factor (EGF, 10 ng/ml) 
from murine salivary gland. KC cultures were passaged when 60% 
confluent, approximately 7 X 104 cells/cmz, and used between pas-
sages 2 and 5. Cell replication studies were conducted using the 
clonal growth assay [17]. Cells growing in the above medium were 
trypsinized and seeded at 2 X 103 cells per 35-mm dish in the modi-
fied keratinocyte basal medium (KBM) to which had been added 
HC and BPE, as above, and EGF (1 ng/ml) and either 500 ng/ml 
bovine insulin (Sigma), or IGF-1 and GH at varying concentra-
tions. Cells were incubated for 12 d without a further change of 
medium, fixed in formaldehyde, stained with crystal violet [18], and 
photographed. 
Melanocyte and 3T3-F442A Fibroblast Cultures Epidermal 
melanocytes were obtained from neonatal foreskin and cultured 
essentially as described [19] in melanocyte growth medium (MGM; 
Clonetics, San Diego, CA). 3T3-F442A fibroblasts (preadipocytes) 
were kindly provided by Dr. Christy Carter-Su, University ofMich-
igan, and cultured as described previously [20]. 
RNA Preparation and Northern Blotting Total RNA prepa-
ration from tissues as well as cultured cells was carried out essentially 
as described [21,22]. Ploy (A)+ -enriched RNA was prepared using a 
commercial kit (Pharmacia, Uppsala, Sweden). After agarose gel 
electrophoresis, total or poly (A)+ RNA was transferred in 10 X 
SSC (lXSSC is 150 mM NaCI, 15 mM sodium citrate, pH 7.0) 
onto Zeta probe membranes (Bio Rad, Richmond, CA). Prehybrid-
ization, hybridization, and washes of blots were performed as de-
scribed in detail elsewhere [22]. 
Polymerase Chain Reaction (PCR) and Semi-Quantitative 
peR PCR was carried out using 1 ,ug of total RNA extracted 
from cultured cells or epidermal biopsies. RNA was reverse tran-
scribed into a complementary DNA [23], using M-MLV H- reverse 
transcriptase (200 units, Gibco BRL) and random hexamers as 
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primers (25 pmol), at 3rc for 30 min, in a total volume of 20 J.LI 
buffer A [50 mM Tris (pH 8.3), 0.3 mM MgClz, 20 mM DTT, 
500 mM dXTP, 20 units RNAse inhibitor]. Forty cycles of PCR 
amplification (94°C, 60 seconds, 50°C, 30 seconds, noc, 90 seC-
onds) were performed in 80,ul using Taq DNA polymerase, buffers, 
and nucleotides as described below for semi-quantitative PCR. 
After amplification, 20,u1 aliquots were analyzed by agarose gel 
electrophoresis as described [23] . These PCR conditions produced 
results that correlated well with Northern blotting. 
The relative amounts of GH-R mRNA levels in KC, FB, and Me 
were determined by semi-quantitative PCR. To 1/1g total RNA 
from each cell type was added 1.2 pg p-globin mRN A (Gibco BRL) 
as an internal control, and the mixtures were reverse transcribed as 
described above. The cDNA thus synthesized was three-fold seri-
ally diluted three times (i.e., the original reaction was diluted 3, 9, 
and 27 times) in buffer A, and to each dilution (20/11) GH-R and 
p-globin specific primers (100 pmol each) were added. GH-R and 
p-globin target sequences were co-amplified by PCR in a total vol-
ume of 80,u1 containing 40 mM Tris-HCl, pH 8.3, 1.5 ~ 
MgClz, 125 mM dXTP, and 2 units Taq DNA polymerase (Perkin 
Elmer Cetus). PCR amplification was carried out for 21 cycles be-
cause we have determined that under these conditions the amount 
of DNA formed is proportional to the amount of input RNA. Fol-
lowing PCR amplification the reaction products were separated b? 
agarose gel electrophoresis and transferred under alkaline condi-
tions to nylon membrane (Nytran, Schleicher and Schuell). Mern-
branes were simultaneously hybridized to random primed 3zp-la-
beled cDNA probes for GH-R and p-globin, as described above .for 
Northern analysis. Radioactivity in each band-was quantified uSing 
a phosphorimager (Molecular Dynamics). Results are expressed as 
GH-R band intensity relative to that of p-globin for each sarnple. 
The oligonucleotide primers for PCR were based on published 
mRNA sequences and were as follows. Three GH-R rnRNA 
primers were to the extracellular domain of the receptor [5], prirner 
1 (5' -CATCGGATCCTCTGGAAGTGAGGCCACAGCAG-
3'), primer 2 (5'-CATCGGATCCCACTCAAGAATGGACT-
CAAGA-3'), and primer 3 (s'-CATCGGATCCGTAAA-
TTGGCTCATCTGAGG-3'); human IGF-1R a-chain [24], 
primer 1 (s'-AA T AACATTGCTTCAGAGCTG-3') and prirner 2 
(s'-GATGGTGCCGTCGGCATACTT-3'); human IGF-l [25J, 
primer 1 (s'-ACGGCTGGACCGGAGACGGTC-3'), prirner 2 
(5'-CT ACTTGCGTTCTTCAAA TGT -3'); and human p_globln, 
primer 1 (5'-GAAGAAGTTGGTGGTGAGGCC-3') and prirner 
2 (s'-ATTGGCCACACCAGCCACCAC-3'). GH mRNA eX-
pression in skin was examined by two degenerate oligonucleotide 
primers designed to the coding sequence of human pituitary GH 
l26) and its corresponding region in bovine [27), primer 1 (s'-A[G~ 
A]CCAT[G/T][T/C]CCTT [G/A]TCC[G/A]G[C/G]C-3') an 
primer 2 (s'-GTCCTTCC[T /G)GAAGCAG[T /G)AGAGCA-
3'). These regions were selected for their high frequency of con-
served nucleotides, thus allowing one set of primers to be use~ for 
dete~t.ion of G H mRN A. from both human skin and bovin~ pit~lta1 
(posItive control). All pnmers were synthesized by the Umverslty 0 
Michigan DNA core facility. Identity of PCR products was con-
firmed (see below) by enzyme restriction mapping, DNA blot hy-
bridiz~tion with 32P-labeled spec!fic cDNA probes, or DNA sef 
quencmg [21,22). Unless otherwise stated, all chemicals were 0 
reagent grade and purchased from commercial sources. 
DNA Probes, eDNA Cloning, and Sequencing A plasrn~d 
clone (num~er 59294) encoding the 30 amino acid signal peptl b~ 
and 193 ammo aCids of the a-subunit of human IGF-1R waS 0 
tained f~om American Type Culture Collection (ATCc) Rockvi~~e, 
MD). Plasmids for the a- and p-chains of insulin receptor were gl;S 
from Dr. Ora Rosen, Sloan-Kettering Cancer Institute. Given t d 
structural similarities and ligand overlap of insulin receptor a.\ 
IGF-1R, Southern blots of human genomic DNA digested wit 
several restriction enzymes were hybridized with insulin recep~or 
and IGF-1R eDNA probes to monitor their specificity and sensl%V-
ity. The porcine IGF-l eDNA clone (designated sigf.3) [22] , as 
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been shown to hybridize to human IGF-1 sequence [21). The GH-R 
cDNA probe was a PCR fragment amplified in this work directly 
from epidermal biopsies. This fragment was gel purified using the 
Geneclean II kit (BIO 101, La Jolla, CA), cleaved by BamHI and 
hgated using T4 DNA ligase [22) into the Bam HI-digested 
pGEM3Z plasmid (Promega, Madison, WI). The p-globin probe 
used for DNA hybridization was also a PCR product. DNA se-
quence analysis and comparison of cloned genes were carried out as 
prevIOusly described [22J . 
Affinity Cross-Linking Studies in Fibroblasts and Keratino-
cytes FB were cultured as above whereas 3T3-F442A cells were 
grown in 100-mm dishes as described previously [20). Cells were 
washed, switched, and maintained in DMEM containing 0.1 % BSA 
for 12-18 h prior to cross-linking experiments. KC were grown as 
above to 60-80% confluency and then switched to modified 
MCDB medium lacking HC, BPE, insulin, and EGF for 48 h. 
Cross-linking experiments were performed as previously described 
[20). Briefly, after rinsing cells in KRP buffer (0.12 M NaCI, 5 mM 
KCI, 1 mM CaCI2, 1.2 mM MgS04' 10 mM NaP04, pH 7.4), 
binding was carried out at 4 ° C for 6 h in the same buffer containing 
1% BSA and 30 ng/ml [125I)-human GH (NEN-DuPont, Wil-
11l1ngton, DE) (for FB and KC) and 10 ng/ml (3T3-F442A) cells. 
These conditions were chosen because lower concentrations ofiodi-
n~ted GH did not produce reproducible results in FB. After washing 
With .cold KRP plus 1 % BSA, cross-linking was perfor~ed . f~r 
15 mm at 4°C in KRP buffer to which was added 1 mM dlsuccml-
midyl suberate (DSS, Pierce Chemical Co., Rockford, IL), freshly 
prepared in DMSO. Celllysates were prepared by detaching mono-
layers in the presence of a solution containing protease inhibitors, 
25 rnM HEPES buffer, 0.1 % Triton X-I00, and 0.5 mM DTT, and 
electrophoresed in 8% polyacrylamide gels with a tris-glycine dis-
Continuous buffer system [20). 
RESULTS 
EXpression of GH-R mRNA and Protein in Human Skin A 
720-base pair (bp) DNA fragment was obtained from human skin 
RNA by reverse transcription using GH-R primers 1 and 3. This 
(DNA fragment was re-amplified with a nested (internal~ 5' -primer GH-R primer 2, nucleotides 270-289) and pnmer 3 yleldmg the 
expected fragment of 523 bp, which also included the 20 bp 
BamHI-adaptor sequence (results not shown). The PCR fragment 
Was cloned into pGEM3Z and digested with BamHI resulting in the 
release from the plasmid vector of a 503-bp insert whereas BamHI/ ~cORV and BamHI/ AvaIl digests each yielded the predicted sub-
ragments (data not shown). The skin-derived PCR product was 
partially sequenced and exhibited 100% homology to the nucleo-
tide sequence of human liver GH-R [5) (results not shown). 
PCR analysis of RNA isolated from cultured cells identified FB, 
rne.lanocytes (MC), and KC as three sources of GH-R RNA tran-
hcnpts in skin (Fig lA, liver is the positive control). Cultures ofKC, 
OWever, were often found to contain 2-4% MC that might have 
~Ontributed to the GH-R mRNA signal detected in these cells by 
CR. Therefore, Northern analysis and semi-quantitative PCR 
were performed to determine the relative abundance of GH-R 
rnRNA in the cultured cells and keratome biopsies. A single GH-R 
rnRNA of5.3-5.5 kbwas detected in poly (A)+RNA thatwas most 
bbundant in FB, but present only at very low levels in KC or skin 
[~op~les (Fig IB) . No mRNA for GHBP, which in rat and mouse 
8J IS expressed from the same transcription unit as GH-R but has a 
b,aller size of approximately 1.2-1.4 kb, was seen in Northern 
Ots. Hybridization of the same RNA blot to the control gene, 
cYclophilin [29)' revealed that equal amounts of poly (A)+ RNA 
were loaded onto the gel (Fig IB). These data indicated that GH-R ~RN.A levels in FB were significantly greater than in KC or skin 
IOpsles. Cell type-specific expression of GH-R mRNA in epider-i al cells was further defined by semi-quantitative PCR analysis. 
/3 hiS revealed that GH-R mRNA transcript levels normalized to the 
t -globin mRNA internal control were approximately equal in cul-
Ured MC and FB (Fig 1 C). In contrast, very low levels of GH-R 
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Figure 1. GH-R gene expression in human skin. A) GH-R mRNA was 
detected by PCR in cultured fibroblasts (FB), melanocytes (Me), keratino-
cytes (Ke), skin, and liver (control) . B) Northern hybridization op2P-la-
beled GH-R probe to poly (A)+ RNA (5 J.l.g) from KC, FB, and skin, or total 
RNA (40 J.l.g) from skin. The absence of a signal in the lane containing total 
RNA indicates that the signal was not due to cross-hybridization of GH-R 
cDNA to 28S ribosomal RNA (B) . The same RNA blot was hybridized 
against cyclophilin cDNA probe, as an internal control for gel loading. 
Positions of 28S and 18S ribosomal RNA markers are shown. C) Semi-
quantitative PCR determiniation (average of three measurements) of GH-R 
mRNA in FB, MC, and KC. Results are normalized to exogenous input 
p-globin mRNA as described in Materials and Methods. 
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Figure 2. Affinity cross-linking of [125I]_GH to its receptor in skin cells. 
GH-R was cross- linked on dermal FB (A, lane 1) orcontrol3T3-F442Acells 
(B, lane 1). Specificity of cross-linked receptor was determined by incubation 
of cell monolayers with iodinated GH in the presence of a hundredfold 
excess; 1 and 3 JIg unlabeled GH for 3T3-F442A and FB, respectively (A and 
B, lane 2). C) Monolayers of KC were incubated with iodinated GH in the 
absence (lane 1) or presence (lane 2) of a hundredfold excess (3 JIg) unlabeled 
GH and cell lysates were run on SDS gels. Abbreviations as in 
Fig 1. 
mRNA were detected in KC by this method (Fig lC), consistent 
with the Northern analysis (Fig 1B). 
We next examined by affinity cross-linking the presence of GH-
R protein in cultured human KC and FB. In intact FB mono layers 
and control 3T3-F442A cells, known to express the membrane 
GH-R [20], [125IJ-GH (10 or 30 ng/ml) formed a complex with 
GH-R ofM, 135 -140 kDa (lane 1 in Fig 2A,B) that was specifically 
reduced by a hundredfold (lor 3 f.lg) excess unlabeled human GH 
(lane 2 in Fig 2A,B). This indicated a protein of about M, 115-
120 kDa for GH-R in both cell types if the M, of iodinated GH was 
subtracted. In contrast, no evidence for expression of GH-R protein 
was observed in cultured KC (lanes 1 and 2, Fig 2C), even under 
conditions where IGF-IR was readily cross-linked (data not 
shown). The cross-linking results were compatible with measure-
ments of GH-R mRNA levels, indicating that FB and MC, but not 
KC, expressed GH-R. This also suggests that FB and MC could 
potentially respond to GH by IGF-l production. 
Pattern of IGF·l mRNA Expression in Skin Expression of 
transcripts for IGF-l, the major mediator of GH effects, was next 
examined in skin cells. Using exon-specific primers, IGF-1 mRNA 
was detected by PCR in human dermal FB, skin (n = 3) and liver 
but not in KC cultures from three individuals (Fig 3A). Cultured 
KC were also negative for IGF-1 mRNA expression by Northern 
blotting (data not shown), which further substantiated the PCR 
data. In a second PCR experiment depicted in Fig 3B, IGF-l mRNA 
expression was demonstrated in FB from a different individual, MC, 
skin, and liver. The integrity of KC RNA samples shown in Fig 
3A,B was confirmed by PCR amplification of cyclophilin [29J, as 
shown. The presence of GH mRNA transcripts in skin was investi-
gated by two degenerate PCR primers. However, no mRNA for 
GH was found in normal human skin, although it was detected in 
bovine pituitary RNA (Fig 3C). Because the results indicated that 
IGF-l was produced in skin cells, we next examined expression of 
receptors for IGF-l in FB, KC, and skin biopsies. 
IGF-l Receptor mRNA Expression IGF-IR mRNA was de-
tected by PCR in FB, KC, and skin (Fig 4A). Liver expressed very 
low levels of IG F-l R transcripts, consistent with a previous report 
[4J. Because the physiologic role ofIGF-l is in part determined by 
the distribution and concentration of its receptors on target cells [4 J, 
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Figure' 3. IGF-l mRNA expression in human epidermal celk A) I~F;;, 
mRNA was detected by PCR in cultured FB, normal human skin (nell. to 
and liver, but not in KC (n = 3). B) IGF-l transcripts were shown by P ,4), 
be expressed in FB (derived from a different individual than one used nica-
in MC, skin, and liver. Integrity ofKC RNA was verified by PCR af~;O bp 
tion of cyclophilin mRNA indicated by an arrow as a fragment 0 human 
above the IGF-l band. C) GH mRNA was undetectable by peR In 'tive 
epidermal biopsies although it was present in bovine pituitary (pOSI 
control). Abbreviations as in Fig 1. 
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Figure 4. IGF-IR gene expression in human epidermal cells. A) IGF-IR 
rnRNA was identified by PCR in FB, KC, and skin, and in lesser amounts III 
bver RNA. B) Relative abundance and size of IGF-IR transcnpts were 
determined by Northern analysis of 50 /lg of total RNA per latle. Multiple 
transcripts of approximately 3 kb, 7 kb, and 11 kb.were detected in FB, KC, 
and skin (n = 3). Abbreviations as in Fig 1. 
(he relative abundance and size ofIGF-1R mRNA transcripts in FB, 
KC, and skin were examined by Northern hybridization. Northern 
analysis revealed that the steady-state levels of IGF-1R mRNA 
(three major species of approximately 3.0, 7.0, and 11 kb) in cul-
tured KC were at least as great as that in FB (Fig 4B). IGF-1 receptor 
transcripts displayed a differential pattern of expression in each cell 
types. Hybridization of the I G F-1 R probe to Southern blots of ge-
nOmic DNA digests produced a profile distinct from that generated 
bY.hYbridization with insulin receptor cDNA, indicating the speci-
ficity of IGF-1R transcripts detected here (results not shown). 
E~~cts of GH and IGF-l on Epidermal Cell Gr~wth The 
abIlity of GH to stimulate growth of dermal FB shown to express 
GB-R was next examined in vitro. In the absence of serum, GH at 
~everal concentrations had no effects on cell numbers or thymidine 
Incorporation into DNA (data not shown), in agreement with 
previous reports [30]. However, addition of GH at 10 ngjml in the 
presence of 0.2% serum stimulated cell replication after 3 d by about 
21 % over serum control (Fig SA, opel! bars). After 5 d, FB cell 
numbers increased by about 70% (p < 0.009) over serum control 
(Fig. SA, solid bars). GH at higher doses (50 ng/ml) had little or no e(~ects on FB growth beyond that achieved by 0.2% serum alone 
Fig SA). 
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Recombinant GH at 5 - 50 ng/ml (data for 20 ngjml shown) had 
no effect in stimulating clonal growth of epidermal KC. In contrast, 
either insulin at 50-5000 ng/ml or IGF-1 at 0.5-50 ng/ml, used 
as control (Fig 5B, data for 5 ngjml IGF-1 and 500 ngjrnl insulin 
shown), promoted clonal growth of KC cultures, consistent with 
previously published data [31]. GH in combination with either in-
sulin or IGF-1 also did not produce any significant effect beyond 
that seen with either insulin or IGF-1 alone as shown (Fig 5B), or at 
several other concentrations used (data not shown). 
DISCUSSION 
GH receptor gene expression has been previously demonstrated in 
epiphyseal chondrocytes and osteoblast-like cells in vitro [12,13) 
and various rat tissues in vivo [6), but not in skin. Thus this report 
constitutes the first direct evidence for expression of GH-R in 
human skin in vivo and cultured human MC and dermal FB in vitro. 
FB and MC cultures used in these studies were essentially free of 
other cell types as the few KC initially present in the primary cul-
tures differentiate on subculturing in the media used to propagate 
FB and MC and thus are subsequently eliminated. KC cultures, 
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Figure 5. Effects of GH on proliferation of cultured human FB and KC. A) 
FB were maintained in DMEM plus 0.2% serum for 48 h prior to the 
indicated treatments on day 1. Cells were counted on day 3 (opetl bars) and 
day 5 (solid bars). Cell numbers are expressed as percentage increase over the 
number of cells on day 1. The bar graphs designated "serum control" indicate 
increases in FB cell numbers in the presence of 0.2% serum alone. Data are 
mean ± SEM of three independent experiments. B) 2 X 103 KC were 
grown in 35-mm dishes in 5 ml modified MCDB medium in the presence of 
the indicated concentrations of either insulin, IGF-l, or GH. Cells were 
incubated for 12 d without a further change of medium and clonal growth 
was measured by colony size [17]. 
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however, may contain 2-4% MC, whose RNA may have signifi-
cantly contributed to the GH-R signal detected by PCR and North-
ern analysis in cultured Ke. Judged by the low GH-R mRNA levels 
in KC cultures and epidermal biopsies, which are themselves com-
posed of 95% KC, we conclude that human KC express probably 
little if any GH-R transcripts. The size of the receptor mRNA in FB 
and skin samples was similar to that reported for the membrane-
bound GH-R mRNA species (4.8-5.1 kb), which mediates GH 
action in liver [5]. Other investigators have also observed a 5.2-kb 
GH-R transcript in human skin (Dr. M.J. Waters, University of 
Queensland, Queensland, Australia, personal communication). We 
have shown that both GH-R mRNA and protein are expressed in 
FB consistent with the expression of membrane-anchored GH-R 
previously reported in other cell types [5,20]. In addition, we have 
directly demonstrated for the first time that the size of membrane-
bound GH receptor is approximately Mr 120 kDa in human 
dermal FB. 
GH-R/GHBP was previously immunolocalized in mammalian 
skin [14]. However, the antibodies utilized in that study recognized 
both the binding protein and membrane-bound receptor [32], mak-
ing it impossible to determine the exact nature of the GH-R in skin 
[14]. On the other hand, based on the specificity of the PCR 
primers, the size of the single GH-R mRNA in Northern blots and 
the size of cross-linked receptor on SDS gels, we conclude that 
human skin expresses the membrane-bound GH-R, which presum-
ably is involved in mediating direct and indirect effects of GH. 
Previous work [30] has shown that GH in vitro is mitogenic within 
its physiologic plasma concentration (10-30 ng/ml) [1,8]. We also 
found that GH at 50 ng/ml did not stimulate FB proliferation in 
vitro. This refractoriness to higher doses of GH has been attributed 
to the incre.ased rate of GH-R internalization, which is believed to 
attenuate GH responsiveness in target cells [28] . 
GH effects are mediated primarily by IGF-l production [30,33] 
and the ability of GH to induce IGF-l production in human FB has 
been previously demonstrated [30]' although this issue was not di-
rectly addressed in the present study. In addition to FB, we found 
IGF-l mRNA transcripts in MC, distinct pigment forming den-
dritic cells in human skin. KC comprise close to 95% of the cells in 
human skin and the ability to proliferate is intrinsic to their basal 
population, which lie immediately adjacent to FB and Me. Because 
both FB and MC express GH-R and have the ability to express 
IGF-1 mRNA, one can speculate that resident MC and dermal FB, 
as shown here, or Langerhans cells [34]' by virtue of their potential 
for IGF-1 production, have the capacity to influence growth of 
epidermal KC in a paracrine fashion. In support of our findings, 
immunoreactive IGF-1 has been recently demonstrated in Langer-
hans cells in UV-irradiated mouse epidermis [34]. 
In agreement with a previous report [31], we found IGF-l to be a 
potent stimulator ofKC growth. Our data also suggest that in KC in 
vitro, the effects of IGF-l are mediated mainly through its own 
receptors rather than through insulin receptors. This conclusion is 
compatible with the extremely low-level binding obtained when 
iodinated insulin has been used in affinity cross-linking studies in 
epidermal KC [31]. Further, the fact that on a molar basis insulin is 
nearly a hundredfold less active in stimulating KC growth than 
IGF-1 [21,31] lends support to our notion. This is also consistent 
with the recent immuno-localization of IGF-IR to basal layers in 
human epidermis [21,35]. 
It is evident that regulation of KC proliferation in skin is under 
the control of a vast array of intrinsic and extrinsic factors produced 
locally with short-distance paracrine or autocrine effects [36]. Given 
the pivotal location of FB and MC in skin, their ability to produce 
I G F-1 may therefore have important implications in regulation of 
epidermal growth, inflammatory conditions, and cutaneous wound 
healing. Although systemic IGF-l may playa critical role in the 
proposed scheme, our results provide circumstantial evidence that 
GH may regulate skin growth through local production ofIGF-1. 
The fact that GH is produced and secreted by immuno-regulatory 
cells [37] emphasizes a potential role for GH/IGF-l axis in tissues 
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other than classical endocrine organs. The extent to which the 
molecular elements identified here actually contribute to normal 
and abnormal cutaneous growth in vivo is currently under investI-
gation. 
We acknowledge the valuable techn ical assistance oj Diatle Boman, Soheila Betlra-
zavi, and Y-j. H. Chow. We are also gratefu l to Mr. Ted HamiltotlJor the statistical 
atlOlyses. We thank Dr. Christy Carter-Su Jar providing the 3T3-F442A fibro-
blasts, and Jar many valuable discussions duritlg this project. 
REFERENCES 
1. Isaksson OGP, Eden S,JanssonJO: Mode of action of pituitary growth 
hormone on target cells. Annu Rev Physiol 47:483-499,1985 
2. Daughaday WH, Hall K, Raben MS, Salmon WD, Van den Brande 
JL, Van WyK JJ: Somatomedin, proposed designation for sulpha-
tion factor. Nature 235:107,1972 
3. Daughaday WH, Rotwein P: Insulin-like growth factor 1 and II per 
tide. messenger ribonucleic acid and gene structure. serum. and tIS-
sue concentrations. Endocr Rev 10:68 - 91. 1989 
4. Foyt HL. Roberts CT Jr: The IGF-1 gene: structure. expression. and 
gene products. In: LeRoith D (ed.). Insulin-like Growth Factors: 
Molecular and Cellular Aspects. CRC Press. Boca Raton. FL. 1991. 
pp 1-16 
5. Leung DW. Spencer AS. Cachianes G. Hammonds RG. Collins C. 
Henzel WJ. Barnard R, Waters MJ; Woqd WI: Growth hormone 
receptor and serum binding protein: purification. cloning and eX-
pression. Nature (London) 330:537-543. 1987 
6. Mathews. LS. Enberg B. Norstedt G: Regulation of rat growth hor-
mone receptor gene expression. J Bioi Chern 264:9905 - 991 0, 1989 
7. Smith WC. Kuniyoshi J. Talamantes F: Mouse serum growth hor-
mone (GH) binding protein has GH receptor extracellular and sub; 
stitute transmembrane domains. Mol EndocrinoI3:984-990. 198 
8. Rudman D. Feller AG. Nagraj HS. Gergans GA. Lalitha PY, Goldber1 AF. Schlenker RA, Cohn L. Rudman IW. Mattson DE: EffectS 0 
growth hormone in men over 60 years old. N Engl J Med 323: 1-6• 
1990 
9. Souhami RL. Moxham J: Textbook of Medicine. Church hill. Living-
stone. London. 1990.683 pp 
10. Barkan AL. Beitins IZ. Kelch RP: Plasma insulin-like growth factorE 1/somatomedin-C in acromegaly: correlation with the degree ~ 
growth hormone secretion. J Cl1l1 EndocTinol Metab 67:69- 7 . 
1988 
11. Isaksson OGP. Jansson JO. Gause lAM: Growth hormone stimulate~ 
longitudinal bone growth directly. Science 216:1237 -1238, 198 
12. Nilsson A. Carlsson B. Mathews L, Isaksson OGP: Growth hormone 
regulation of the growth hormone receptor mRNA in cultured ra~ 
epiphyseal chondrocytes. Mol Cell Endocrinol 70:237 - 246. 199 
13. Barnard R. Ng KW. Martin TJ. Waters MJ: Growth hormone (GJ-I) 
receptors in clonal osteoblast-like cells mediate a mitogenic response 
to GH. Endocrinology 128:1459-1464. 1991 
14. Lobie PE. Breipohl W. Lincoln DT. Garcia-Aragon]. Waters M]: 
Localization of growth hormone receptor/binding protein in skin.] 
Endocrinol 126:467-472. 1990 
15. Voorhees J]. Duell EA. Bass LJ. Powell JA. Harrell ER: Decreased 
cyclic AMP in the epidermis of lesions of psoriasis. Arch Derm 
105:695-701.1972 f 
16. Wille JJ. Pittelkow MR, Shipley GD. Scott RE: Integrated control 1-
growth and differentiation of normal human prokeratinocytes CU d 
tured in serum-free medium: clonal analyses. growth kinetiCS. an 
. cell cycle studies.] Cell PhysioI121:31-44, 1984 I 
'd rna 17. Tsao MC. Walt~all B]. Ham RG: Clonal growth o~human epl ~~29. 
kerat1l10cytes 111 a defined medIUm. J Cell PhyslOl 110:219 
1982 
. tes In: 18. Boyce ST. Ham RG: Normal human epidermal keraunocy . h 
Weber MM. Sekely LI (eds.). In Vitro Models for Cancer Researc . 
CRC Press. Boca Raton. FL. 1986, pp 245-274 I 
19. Eisinger M. Marko 0 : Selective proliferation of normal human me a-
VOL. 99, NO.3 SEPTEMBER 1992 
nocytes in vitro in the presence of phorbol ester and cholera toxin. 
Proc Nat! Acad Sci USA 79:2018-2022, 1982 
20. Carter-Su C, Schwartz J, Kikuchi G: Identification of a high-affinity 
growth hormone receptor in rat adipocytes. J Bioi Chern 
259:1099-1104,1983 
21. Tavakkol A, Keane KM, Griffiths CEM, Fisher GJ, Voorhees JJ: Ex-
pression of GH receptor, IGF-1 and IGF-1 receptor in human skin 
may explain the ability of systemically administered growth hor-
mone to thicken human skin (abstr) . J Invest Dermatol 96:192A, 
1991 
22. Tavakkol A, Simmen FA, Simmen RCM: Porcine insulin-like growth 
factor-1 (pIGF-1): complementary deoxyribonucleic acid .cloning 
and uterine expression of messenger rIbonucleic aCid encodmg evo-
lutionarily conserved IGF-1 peptides. Mol EndocrinoI2:674-681, 
1988 
23. Kawasaki ES: Amplification of RNA, Chapter 3. In: Innis MA, Gel-
fand DH, Sninsky]] (eds.). PCR Protocols: A gUide to Methods and 
Applications. Academic Press, 1990, PP 21-27 
24. Ullrich A, Gray A, TamAW, Yang-FengT, TsubokawaM, Collins C, 
Henzel W , Le Bob T , Kathuria S, Chen E, Jacobs S, Francke U, 
Ramachandran] , Fujita-Yamaguchi Y: Insulin-like growth factor 1 
receptor primary structure: comparison with insu.lin receptor sug-
gests structural determinants that define functIOnal speCifiCity. 
EMBO J 5:2503-2512,1986 
25 . de Pagter-Holthuizen P, van Schaik FMA, Verduijn e M, van Ommen 
GJB, Bouma BN, Jansen M, Sussenbach JS: Organization of the 
human genes for insulin-like growth factors I and II. FEBS Lett 
195:179-184,1986 
26. Roskam WG, Rougeon F: Molecular cloning and nucleotide sequence 
of the human growth hormone structural gene. Nucl Acids Res 
7:305-320,1979 
27. Miller WL, Martial] A, Baxter ]D: Molecular cloning of DNA comple-
mentary to bovine growth hormone mRNA. ] BIOI Chern 
255:7521 - 7524, 1980 
GH/ IGF-I AXIS IN HUMAN SKIN 349 
28. Hochberg Z, Amit T, You dim MBH: The growth hormone binding 
protein as a paradigm of the erythropoietin superfamily of receptors. 
Cell Signalling 3:85 - 91, 1991 
29 . Haendler B, Hofer-Warbinek R, Hofer E: Complementary DNA for 
human T-cell cyclophilin. EMBO ] 6:947 - 950, 1987 
30. Cook JJ, Haynes KM, Werther GA: Mitogenic effects of growth 
hormone in cultured human fibroblasts. Evidence for action via local 
insulin-like growth factor 1 production. J Clin Invest 81 :206 - 212, 
1988 
31. Neely KE, Morhenn VB, Hintz RL, Wilson DM, Rosenfeld RG: 
Insulin-like growth factors are mitogenic for human keratinocytes 
and a squamous cell carcinoma. ] Invest Dermatol 96:104-110, 
1991 
32. Barnard R, Bundesen PG, Rylatt DB, Waters MJ: Evidence from the 
use of monoclonal antibody probes for structural heterogeneity of 
the growth hormone receptor. Biochem J 231 :459 - 468, 1985 
33. Murphy L], Vrhovsek E, Lazarus L: Identification and characterization 
of specific growth hormone receptors in cultured human fibroblasts . 
] Clin Endocrin Metab 57:1117 -1124, 1983 
34. Hansson HA, Jonsson R, Petruson K: Transiently increased insulin-
like growth factor 1 immunoreactivity in UVB-irradiated mouse 
skin.] Invest Dermatol 91:328-332, 1988 
35. Krane JF, Murphy DP, Carter DM, Krueger ]G: Synergistic effects of 
epidermal growth factor (EGF) and insulin-like growth factor 1/so-
matomedin C (IGF-1) on keratinocyte proliferation may be me-
diated by IGF-1 transmodulation of the EGF receptdr. J Invest Der-
matol 96:419-424,1991 
36. Gilchrest BA, Karassik RL, Wilkins LM, Vrabel MA, Macaig T: Auto-
crine and paracrine growth stimulation of cells derived from human 
skin. ] Cell Physiol 117:235 - 240, 1983 
37. Weigent DA, Blalock ]E: The production of growth hormone by 
subpopulations of rat mononuclear leukocytes. Cellular Immunol 
135:55-65,1991 
